• Attorneys
  • Practices & Industries
  • Thought Leadership +
    • Videos
    • Podcasts
    • Publications
      • Chemical Law & Prop 65 Blog
    • Webinars
  • News & Events +
    • News
    • Events/
      Speaking Engagements
  • About
  • Careers
  • Diversity
  • Contact
  • Offices
  • Payment Portal +
    • Pay your invoice
    • Pay your retainer
Buchalter
  • About
  • Careers
  • Diversity
  • Contact
  • Offices
  • Attorneys
  • Practices & Industries
  • Thought Leadership +
    • Publications
      • Chemical Law & Prop 65 Blog
    • Webinars
    • Videos
    • Podcasts
  • News & Events +
    • News
    • Events/
      Speaking Engagements
  • Payment Portal +
    • Pay your invoice
    • Pay your retainer
« View All News

Buchalter Successfully Represented Ruifeng Biztech, Inc. in a First-of-its Kind Motion to Dismiss Claims Under the Federal Defend Trade Secrets Act

Buchalter recently represented Ruifeng Biztech, Inc., in what may be a first-of-its kind ruling, on March 13, 2021, the Northern District of California granted Ruifeng Biztech’s motion to strike nine of Quintara Biosciences, Inc.’s alleged DNA sequencing trade secrets, leaving plaintiff with only its customer list and vendor list claims to support its allegations under the federal Defend Trade Secrets Act.

On November 20, 2020, the Court granted Ruifeng’s motion for a protective order under California Code of Civil Procedure section 2019.210, which requires that a trade secret plaintiff set forth with “reasonable particularity” its alleged trade secrets.  The Court’s November 18, 2020 order also commanded Quintara to set forth the specifics of each alleged trade secret, including how it met the Defend Trade Secrets Act’s definition of a “trade secret.”  The court explained “The point is to nail down the asserted trade secrets with sufficient particularity to permit us to discern the reasonable bounds of discovery, to give defendants notice to mount a cogent defense, and to prevent plaintiff from indulging in shifting sands.”

When the plaintiff failed to comply with the Court’s November 20, 2020 order, Ruifeng successfully moved to strike and dismiss Quintara’s DNA sequencing trade secrets allegations.

The Buchalter team was led by Dylan Wiseman, Tiffany Ng, and Brandon Carr.

Additional Coverage

  • Trademark Lawyer Magazine
Share

Related Areas

  • Trade Secrets & Employee Mobility

Related Attorneys

  • Dylan W. Wiseman
  • Tiffany F. Ng
  • Brandon Carr
Buchalter footer logo

Adam Bass, Buchalter President & CEO

  • About
  • Careers
  • News & Events
  • Subscribe
  • CA Privacy Notice
  • PI Opt-Out
  • Denver
  • Los Angeles
  • Napa Valley
  • Orange County
  • Portland
  • Sacramento
  • Salt Lake City
  • San Diego
  • San Francisco
  • Scottsdale
  • Seattle
  • © Copyright 2023 Buchalter, A Professional Corporation
Buchalter Communications

We love sharing our knowledge, but we don't want to inundate you. If you would like to receive communications from Buchalter, please highlight the text boxes below indicating which type of communications you would like to receive, and provide your name and email address. [Street address is only necessary for Points and Authorities.] We appreciate your interest in our work.

  • This field is for validation purposes and should be left unchanged.
  • Sign Up